Master Protocols for Drug and Biological Product Development; Guidance for Industry; Draft Guidance
FDA-2023-D-5259-0002Other
Comments
26
Last activity Jun 23, 2026
Deadline
Closed on Mar 22, 2024
Closed Mar 22, 2024
Net supportiSupport minus oppose · campaigns included
+81%
+81% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Master Protocols for Drug and Biological Product Development; Guidance for Industry; Draft Guidance
- Posted
- Dec 22, 2023
- Comment period
- Dec 22, 2023 – Mar 22, 2024
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
+81%
Net support
Support22Oppose1Other3
Aggregates include form-letter campaigns. Excluding them, net support is +81% across organic comments.
Who commented
Breakdown by commenter type.
Other
1
Academic
5
Business
8
Government
1
Individual
6
Trade association
1
Advocacy
4
Comments over time
Weekly arrivals, stacked by stance.
Posted Dec 22, 2023Deadline Mar 22, 2024
Dec 25Jan 29Feb 12Mar 4Nov 17Jun 22
Support22Oppose1Other3
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Business
100%
0%
0%
Individual
33%
17%
50%
Academic
100%
0%
0%
Advocacy
100%
0%
0%
Government
100%
0%
0%
Other
100%
0%
0%
Trade association
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Master protocol design | Master protocols guidance |
|---|
2 organization-typed comments could not be identified.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.